Latest market price
16.03
-0.17-1.05%
OverviewShort InterestFilings
SMMTQT57Summit Therapeutics Inc.·NASDAQ
16.03-1.05%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 19, 2026DEF 14ADefinitive proxy statement
Oct 14, 20264Statement of changes in beneficial ownership
Oct 06, 2026PRE 14APreliminary proxy statement
Sep 29, 20268-KCurrent report
Sep 15, 20268-KCurrent report
Sep 14, 20268-KCurrent report
Sep 03, 20268-KCurrent report
Aug 26, 20268-KCurrent report
Aug 05, 20268-KCurrent report
Jul 23, 20268-KCurrent report
Jul 23, 20268-KCurrent report
Jul 23, 2026424B5Prospectus
Jul 23, 202610-QQuarterly report
Jul 22, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 11, 20268-KCurrent report
Jun 10, 2026424B5Prospectus
Jun 09, 2026S-3ASRS-3ASR
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 03, 20268-KCurrent report
Jun 01, 20268-KCurrent report
#1 / 25 of 283
Page
▼
/ 12